AV

Anoop Vaish

Active Director Director DIN 07118806
DIN 07118806 First appointment Apr 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Anoop Vaish

Data last updated:

Anoop Vaish is a Director at Eigen Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Eigen Pharmaceuticals Private Limited reported revenue of ₹11.9 Lakh (FY 2020).

DIN 07118806
Primary Designation Director
Industry Trading
First Appointment 07 Apr 2015
Oldest Company Age 11 yrs
Largest company Eigen Pharmaceuticals Private Limited · ₹11.9 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20152015₹11.9 Lakh (FY 2020)Active

Board colleagues of Anoop Vaish

NameDINCompanyDesignation
Manoj Vaish08013455Eigen Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eigen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anoop Vaish

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anoop Vaish

Anoop Vaish currently holds 1 directorship: Eigen Pharmaceuticals Private Limited (Director, since 07 Apr 2015, revenue ₹11.9 Lakh (FY 2020)).

Anoop Vaish was first appointed on 07 Apr 2015 as Director at Eigen Pharmaceuticals Private Limited.

The current boards of Anoop Vaish's companies include Manoj Vaish (Eigen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available